ALB vs VTVT · rev $1.74B vs rev $36.8M
Albemarle Corp (ALB) versus vTv Therapeutics Inc (VTVT) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
vTv Therapeutics Inc (VTVT) is a biotechnology company listed on NASDAQ.
Latest reported ALB revenue for 2026-06-30 was $1.74B. Net income was $480.0M. Revenue was up 22.0% from 2026-03-31 to 2026-06-30. ALB currently screens at market cap $8.00B.
Latest reported VTVT revenue for 2026-06-30 was $36.8M. Net income was $11.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. VTVT currently screens at market cap $133.9M.
ALB currently screens at market cap $8.00B. VTVT currently screens at market cap $133.9M.
Not investment advice. Open the ALB and VTVT stock pages for the full models.
Not investment advice.